Sinai Intellectual Property Co Cedars, 10% Owner at Prometheus Biosciences, Inc. (RXDX), sold 865,000 shares at $114.59 ($99.1M) on 2023-03-08, disclosed to the SEC on 2023-03-08.
Open-market sale of $99.1M RXDX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.